6 Danish healthcare stocks with +20% return, index continues up and outperforms, Gubra’s CEO selling
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week the Nordic
Denne side giver inspiration til investeringer inden for Life Science samt small og mid caps i Skandinavien og er udarbejdet af Kapital Partners analyseteam. Vi udarbejder investeringscases på selskabs-, markeds- og sektorniveau. Få investeringcasene i din indbakke ved at tilmelde dig vores nyhedsbrev her.
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week the Nordic
The Nordic impact sectors experienced notable differences last week. Multiple sectors rose 6%, while Mobility declined 14%. At the same
I sidste uge steg både KPNGX- og TRVCI-indekset, mens C25- og S30-indekset faldt en anelse. Ugens mest stigende aktie steg
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full
All of the Nordic impact sectors declined in the past week. The CO2 & Carbon Capture only fell -0.4%, whereas
I sidste uge steg C25-, S30- og TRVCI-indekset en anelse, mens KPNGX-indekset omvendt faldt en smule. Ugens mest stigende aktie
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: CS Medica, EKOBOT AB, Biotech, Ensurge, Lifecare AS, NORD.investments, Biosergen, Hypefactors, Curasight, Re-Match, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.